What ferritin, transferrin saturation, and hemoglobin thresholds indicate the need for intravenous iron infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Infusion Thresholds

Intravenous iron infusion is warranted when ferritin is <100 ng/mL with transferrin saturation <20%, or when ferritin is <30 ng/mL regardless of transferrin saturation in the setting of anemia requiring treatment. 1

Absolute Iron Deficiency Thresholds

Ferritin <30 ng/mL with transferrin saturation <15% defines absolute iron deficiency and warrants IV iron supplementation. 1 This represents the most sensitive and specific threshold for identifying true iron depletion. 1

  • In the presence of inflammation (C-reactive protein >5 mg/L), the ferritin threshold increases to <100 ng/mL because ferritin is an acute-phase reactant that can be falsely elevated. 1
  • These patients should receive IV iron regardless of hemoglobin level if they are symptomatic or undergoing treatment that will worsen anemia. 1, 2

Functional Iron Deficiency Thresholds

Ferritin <800 ng/mL AND transferrin saturation <20% defines functional iron deficiency in patients on erythropoiesis-stimulating agents or chemotherapy. 1 This scenario indicates iron stores exist but cannot be mobilized effectively for red cell production.

  • IV iron has superior efficacy over oral iron in this setting and should be strongly considered. 1
  • The NCCN guidelines specifically state that ferritin <800 ng/mL with TSAT <20% warrants IV iron supplementation in cancer patients receiving chemotherapy. 1

Context-Specific Thresholds

Perioperative/Colorectal Surgery

  • Target preoperative hemoglobin of ≥130 g/L should be pursued. 1
  • Ferritin <100 µg/L with transferrin saturation <20% in the presence of inflammation indicates need for IV iron. 1
  • Oral iron is ineffective in inflammatory bowel disease due to hepcidin activation; IV iron overcomes this problem. 1

Chronic Kidney Disease

  • Ferritin ≤100 ng/mL OR transferrin saturation ≤20% triggers IV iron initiation. 1
  • Stop IV iron when ferritin ≥800 ng/mL AND TSAT ≥20%, OR when TSAT ≥40%. 1
  • These thresholds apply to both dialysis-dependent and non-dialysis-dependent CKD patients. 1, 3

Heart Failure

  • Transferrin saturation is more prognostically significant than ferritin in heart failure patients. 4
  • Low TSAT (typically <20%) is associated with adverse outcomes regardless of ferritin level. 4
  • Current ID definitions (ferritin <100 or 100-299 ng/mL with TSAT <20%) should guide treatment decisions. 4

Dosing Considerations

Total iron dose calculation:

  • 1500 mg for patients with hemoglobin 7-10 g/dL and weight <70 kg. 2
  • 2000 mg for patients with hemoglobin 7-10 g/dL and weight ≥70 kg. 2
  • Typically administered as 1-2 infusions depending on formulation. 2

Formulation-specific limits:

  • Iron sucrose: 200-300 mg per dose. 2, 3
  • Ferric carboxymaltose: up to 1000 mg per dose (preferred for higher doses). 2
  • Iron dextran: requires test dose due to anaphylaxis risk. 2, 5

Upper Safety Limits

Stop IV iron when:

  • Transferrin saturation >50% 1, 2, 6
  • Ferritin >800 ng/mL (some sources suggest 1000 ng/mL as absolute upper limit) 1, 2, 6

These upper limits prevent iron overload and potential toxicity, though evidence suggests harm primarily occurs at dramatically higher ferritin levels. 1

Important Clinical Caveats

  • Do not administer IV iron in the presence of active infection. 2
  • Ferritin alone is unreliable in inflammatory states; always interpret with transferrin saturation and clinical context. 1, 7
  • The scenario of ferritin >800 ng/mL with TSAT <20% has become increasingly common with multiple comorbidities, and limited evidence suggests IV iron may still benefit selected patients, though safety data are insufficient. 1, 7
  • Reticulocyte hemoglobin content ≥31.2 pg predicts better response to IV iron, though lower values do not preclude benefit. 8
  • Oral iron absorption is only 40-60 mg per day and is poorly tolerated; IV iron is more effective for rapid repletion. 1, 6

Monitoring After Treatment

  • Recheck hemoglobin, ferritin, and transferrin saturation 8-10 weeks after IV iron administration. 2
  • Target ferritin >100 ng/mL to ensure adequate iron stores. 2
  • Reticulocytosis occurs 3-5 days after administration; mean hemoglobin increase is approximately 8 g/L over 8 days. 1

Related Questions

At what percent transferrin saturation should iron therapy be started?
What is the Transferrin Saturation (TSAT) for a patient with a serum iron level of 32.5 umol/L and a transferrin level of 2.53 g/L?
Should iron supplementation be initiated with a ferritin level of 54.9 and transferrin saturation of 25%?
Are there any interactions between Vyvanse (lisdexamfetamine) and iron supplements in patients with iron deficiency?
Can iron supplements be given to patients with elevated ferritin (iron storage protein) levels?
What preventive health assessment, immunizations (Tdap [tetanus, diphtheria, pertussis] booster, HPV [human papillomavirus] vaccine series, MenACWY [meningococcal conjugate] vaccine, COVID‑19 vaccine), screenings, and counseling are recommended for a 14‑year‑old female during a routine well‑child visit?
How should I evaluate a 45‑year‑old woman with menstrual irregularities, hot flashes, sleep disturbance, mood changes, weight gain, acne, hair loss, and pelvic pain to determine if these symptoms are due to perimenopause rather than another condition?
In a 65-year-old man with new weekly 30-minute unilateral retro-orbital headaches and occasional visual aura, is neuroimaging indicated and which imaging modality is preferred?
What is the appropriate initial evaluation and treatment for a 7‑day history of acute right‑sided low back pain without red‑flag symptoms?
How do peripheral arterial disease (PAD) and lymphadenopathy differ regarding pathophysiology, clinical presentation, diagnostic work‑up, and management?
After my in‑vitro fertilisation embryo transfer, what emotional and physical symptoms are expected and what findings would require urgent medical attention?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.